Business Description
Sichuan Zitonggong Pharmaceutical Co Ltd
ISIN : CNE100004MP0
Compare
Compare
Traded in other countries / regions
832566.China IPO Date
2021-08-13Description
Sichuan Zitonggong Pharmaceutical Co Ltd is a high-tech enterprise focusing on the R&D, production, and marketing of tablets, hard capsules, liniments, powders, and ointments. It has developed a number of drug varieties such as Citicoline Sodium Tablets and Rizatriptan Benzoate Capsules.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 24.26 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.12 | |||||
| Interest Coverage | 168.12 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.5 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.1 | |||||
| 3-Year EBITDA Growth Rate | 3.9 | |||||
| 3-Year EPS without NRI Growth Rate | 7.3 | |||||
| 3-Year FCF Growth Rate | 38.8 | |||||
| 3-Year Book Growth Rate | 15.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.86 | |||||
| 9-Day RSI | 37.39 | |||||
| 14-Day RSI | 39.97 | |||||
| 6-1 Month Momentum % | 83.55 | |||||
| 12-1 Month Momentum % | 46.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.12 | |||||
| Quick Ratio | 6.44 | |||||
| Cash Ratio | 4.69 | |||||
| Days Inventory | 189.55 | |||||
| Days Sales Outstanding | 94.86 | |||||
| Days Payable | 91.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.56 | |||||
| Dividend Payout Ratio | 0.57 | |||||
| Forward Dividend Yield % | 3.56 | |||||
| 5-Year Yield-on-Cost % | 3.38 | |||||
| 3-Year Average Share Buyback Ratio | -8.8 | |||||
| Shareholder Yield % | 2.76 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.01 | |||||
| Operating Margin % | 26.04 | |||||
| Net Margin % | 23.01 | |||||
| FCF Margin % | 15.78 | |||||
| ROE % | 12.72 | |||||
| ROA % | 10.67 | |||||
| ROIC % | 19.81 | |||||
| ROC (Joel Greenblatt) % | 52.7 | |||||
| ROCE % | 13.46 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.71 | |||||
| PE Ratio without NRI | 16.9 | |||||
| Shiller PE Ratio | 23.34 | |||||
| Price-to-Owner-Earnings | 24.65 | |||||
| PEG Ratio | 1.82 | |||||
| PS Ratio | 3.84 | |||||
| PB Ratio | 2.01 | |||||
| Price-to-Tangible-Book | 2.4 | |||||
| Price-to-Free-Cash-Flow | 24.13 | |||||
| Price-to-Operating-Cash-Flow | 14.65 | |||||
| EV-to-EBIT | 12.01 | |||||
| EV-to-EBITDA | 12.01 | |||||
| EV-to-Revenue | 3.19 | |||||
| EV-to-FCF | 20.2 | |||||
| Price-to-Projected-FCF | 1.36 | |||||
| Price-to-Graham-Number | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 4.16 | |||||
| Price-to-Net-Cash | 8.05 | |||||
| Earnings Yield (Greenblatt) % | 8.33 | |||||
| FCF Yield % | 4.49 | |||||
| Forward Rate of Return (Yacktman) % | 8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sichuan Zitonggong Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 410.012 | ||
| EPS (TTM) (Â¥) | 0.62 | ||
| Beta | 1.13 | ||
| Volatility % | 50.02 | ||
| 14-Day RSI | 39.97 | ||
| 14-Day ATR (Â¥) | 1.09692 | ||
| 20-Day SMA (Â¥) | 11.964 | ||
| 12-1 Month Momentum % | 46.03 | ||
| 52-Week Range (Â¥) | 6.31 - 15.44 | ||
| Shares Outstanding (Mil) | 146.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sichuan Zitonggong Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sichuan Zitonggong Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sichuan Zitonggong Pharmaceutical Co Ltd Frequently Asked Questions
What is Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566)'s stock price today?
The current price of BJSE:832566 is ¥9.82. The 52 week high of BJSE:832566 is ¥15.44 and 52 week low is ¥6.31.
When is next earnings date of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566)?
The next earnings date of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) is .
Does Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) pay dividends? If so, how much?
The Dividend Yield %  of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) is 3.56% (As of Today), Highest Dividend Payout Ratio of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) was 0.81. The lowest was 0.23. And the median was 0.44. The  Forward Dividend Yield % of Sichuan Zitonggong Pharmaceutical Co Ltd(BJSE:832566) is 3.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers